Radiological analysis of children with cystic fibrosis who are homozygous for cystic fibrosis transmembrane conductance regulator mutation S549R (T → G)
Frossard, P.M.; Bakalinova, D.; Hertecant, J.; Bossaert, Y.; Dawson, K.P.
Journal of Tropical Pediatrics (1980) 45(3): 158-160
1999
ISSN/ISBN: 0142-6338 Accession: 077497797
Full Text Article emailed within 1 workday: $29.90
Related References
Frossard, P. 1999: Radiological analysis of children with cystic fibrosis who are homozygous for cystic fibrosis transmembrane conductance regulator mutation S549R (T->G) Journal of Tropical Pediatrics 45(3): 158-160Frossard, P.M.; Bakalinova, D.; Hertecant, J.; Bossaert, Y.; Dawson, K.P. 1999: Radiological analysis of children with cystic fibrosis who are homozygous for cystic fibrosis transmembrane conductance regulator mutation S549R (T-->G) Journal of Tropical Pediatrics 45(3): 158-160
Sermet-Gaudelus, I.; Boeck, K.D.; Casimir, G.J.; Vermeulen, F.ço.; Leal, T.; Mogenet, A.ès.; Roussel, D.; Fritsch, J.; Hanssens, L.; Hirawat, S.; Miller, N.L.; Constantine, S.; Reha, A.; Ajayi, T.; Elfring, G.L.; Miller, L.L. 2010: Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis American Journal of Respiratory and Critical Care Medicine 182(10): 1262-1272
Graeber, S.Y.; Dopfer, C.; Naehrlich, L.; Gyulumyan, L.; Scheuermann, H.; Hirtz, S.; Wege, S.; Mairbäurl, H.; Dorda, M.; Hyde, R.; Bagheri-Hanson, A.; Rueckes-Nilges, C.; Fischer, S.; Mall, M.A.; Tümmler, B. 2018: Effects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis American Journal of Respiratory and Critical Care Medicine 197(11): 1433-1442
Berges, J.; Graeber, S.Y.; Hämmerling, S.; Yu, Y.; Krümpelmann, A.; Stahl, M.; Hirtz, S.; Scheuermann, H.; Mall, M.A.; Sommerburg, O. 2023: Effects of lumacaftor-ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2-11 years Frontiers in Pharmacology 14: 1188051
Derichs, N.; Mekus, F.; Bronsveld, I.; Bijman, J.; Veeze, H.J.; von der Hardt, H.; Tummler, B.; Ballmann, M. 2003: Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients Pediatric Research 55(1): 69-75
Clain, J.; Fritsch, J.; Lehmann-Che, J.; Bali, M.; Arous, N.; Goossens, M.; Edelman, A.; Fanen, P. 2000: Two mild cystic fibrosis-associated mutations result in severe cystic fibrosis when combined in cis and reveal a residue important for cystic fibrosis transmembrane conductance regulator processing and function Journal of Biological Chemistry 276(12): 9045-9049
Mathew, A.; Dirawi, M.; Abou Tayoun, A.; Popatia, R. 2021: A Rare Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation Associated with Typical Cystic Fibrosis in an Arab Child Cureus 13(2): E13526
Rubenstein, R.C. 2006: Targeted therapy for cystic fibrosis: cystic fibrosis transmembrane conductance regulator mutation-specific pharmacologic strategies Molecular Diagnosis and Therapy 10(5): 293-301
Mickle, J.E.; Macek, M.; Fulmer-Smentek, S.B.; Egan, M.M.; Schwiebert, E.; Guggino, W.; Moss, R.; Cutting, G.R. 1998: A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis Human Molecular Genetics 7(4): 729-735
Velard, F.éd.ér.; Delion, M.; Le Henaff, C.; Guillaume, C.; Gangloff, S.; Jacquot, J.; Tabary, O.; Touqui, L.; Barthes, F.ço.; Sermet-Gaudelus, I. 2014: Cystic fibrosis and bone disease: defective osteoblast maturation with the F508del mutation in cystic fibrosis transmembrane conductance regulator American Journal of Respiratory and Critical Care Medicine 189(6): 746-748
Thibodeau, P.H.; Richardson, J.M.; Wang, W.; Millen, L.; Watson, J.; Mendoza, J.L.; Du, K.; Fischman, S.; Senderowitz, H.; Lukacs, G.L.; Kirk, K.; Thomas, P.J. 2010: The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis Journal of Biological Chemistry 285(46): 35825-35835
Gee, H.Y.; Kim, C.K.; Kim, S.W.; Lee, J.H.; Kim, J.-H.; Kim, K.H.; Lee, M.G. 2010: The L441P mutation of cystic fibrosis transmembrane conductance regulator and its molecular pathogenic mechanisms in a Korean patient with cystic fibrosis Journal of Korean Medical Science 25(1): 166-171
Bieger, A.éi.M.; Marson, F.A.d.L.; Bertuzzo, C.S.íl. 2012: Prevalence of ΔF508 mutation in the cystic fibrosis transmembrane conductance regulator gene among cystic fibrosis patients from a Brazilian referral center Jornal de Pediatria 88(6): 531-534
Peters, K.W.; Gong, X.; Frizzell, R.A. 2021: Cystic Fibrosis Transmembrane Conductance Regulator Folding Mutations Reveal Differences in Corrector Efficacy Linked to Increases in Immature Cystic Fibrosis Transmembrane Conductance Regulator Expression Frontiers in Physiology 12: 695767
Fredj, S.H.; Messaoud, T.ïe.; Templin, C.; des Georges, M.; Fattoum, S.; Claustres, M. 2009: Cystic fibrosis transmembrane conductance regulator mutation spectrum in patients with cystic fibrosis in Tunisia Genetic Testing and Molecular Biomarkers 13(5): 577-581
Ren, C.L.; Morgan, R.L.; Oermann, C.; Resnick, H.E.; Brady, C.; Campbell, A.; DeNagel, R.; Guill, M.; Hoag, J.; Lipton, A.; Newton, T.; Peters, S.; Willey-Courand, D.Beth.; Naureckas, E.T. 2018: Cystic Fibrosis Foundation Pulmonary Guidelines. Use of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy in Patients with Cystic Fibrosis Annals of the American Thoracic Society 15(3): 271-280
Thomas, P.J.; Shenbagamurthi, P.; Sondek, J.; Hullihen, J.M.; Pedersen, P.L. 1992: The cystic fibrosis transmembrane conductance regulator. Effects of the most common cystic fibrosis-causing mutation on the secondary structure and stability of a synthetic peptide Journal of Biological Chemistry 267(9): 5727-5730
Macek, M.; Hamosh, A.; Kiesewetter, S.; McIntosh, I.; Rosenstein, B.J.; Cutting, G.R. 1992: Identification of a novel nonsense mutation (L88X) in exon 3 of the cystic fibrosis transmembrane conductance regulator gene in a native Korean cystic fibrosis chromosome Human Mutation 1(6): 501-502
Raju, S.Vamsee.; Lin, V.Y.; Liu, L.; McNicholas, C.M.; Karki, S.; Sloane, P.A.; Tang, L.; Jackson, P.L.; Wang, W.; Wilson, L.; Macon, K.J.; Mazur, M.; Kappes, J.C.; DeLucas, L.J.; Barnes, S.; Kirk, K.; Tearney, G.J.; Rowe, S.M. 2017: The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke American Journal of Respiratory Cell and Molecular Biology 56(1): 99-108